Skip to main content
. 2021 Sep 9;58(3):352–362. doi: 10.23736/S1973-9087.21.07048-9

Table I. —Patient demographics.

Variables Total Severe ankle impairment group
(N.=15)
Mild ankle impairment group
(N.=17)
P value
Age, years 48.3±20.0 44.0±20.6 52.0±19.2 0.265
Height, cm 165.3±8.6 166.3±8.1 164.4±9.1 0.529
Weight, kg 60.8±14.4 60.5±15.2 61.0±14.1 0.934
Sex, male/female 22/10 11/4 11/6 0.599
Diagnosis, intracerebral hemorrhage/cerebral infarction 11/21 6/9 5/12 0.529
Time after stroke, days 140 (65-2439) 322 (70-2439) 82 (65-1768) 0.025*
Affected side, right/left 17/15 6/9 11/6 0.162
Score of lower extremity motor function on the SIAS 9.9±1.8 8.5±1.3 11.1±1.2 <0.0001**
Hip-flexion test 3.7±0.5 3.5±0.5 3.9±0.3 0.033*
Knee-extension test 3.5±0.6 3.3±0.6 3.6±0.6 0.058
Foot-tap test 2.7±1.1 1.7±0.6 3.5±0.6 <0.0001**
Treadmill speed, km/h 2.7±0.8 2.4±0.7 2.9±0.7 0.101
Functional ambulation categories 4.6±0.5 4.7±0.5 4.5±0.5 0.451
Type of AFO, tAFOs/APS-AFOs 15/17 7/8 8/9 0.982

*P<0.05; **P<0.01. AFO: ankle-foot orthosis; APS-AFO: adjustable posterior strut-AFO; SIAS: stroke impairment assessment set; tAFO: thermoplastic AFO.